38 people who flouted Covid-19 rules were sentenced to three months in prison each by a Thika Court.
In his ruling, Thika Resident Magistrate Oscar Wanyaga offered the convicts an alternative to each pay a fine of Ksh5,000.
The suspects pleaded guilty to charges of flouting curfew orders as directed by the Ministry of Health in an attempt to curb the spread of the Covid-19 virus.
The group was arrested in different parts of Kiambu County. Some were arrested for not wearing facemasks and others had contravened curfew hours.
“I am forgiving you because of your child but I am putting you on a suspended sentence. When you commit another offense within six months, you will be sent to prison,” stated Wanyaga.
This comes as Coronavirus continues to pummel the country with many hospitals reportedly running out of room for accommodating patients.
But the good news is that Kenyans are likely to receive the Pfizer-BioNTech vaccine, which has been found to be effective in preventing Covid-19, next year.
Results released on Monday show it is more than 90 per cent effective against coronavirus.
The manufacturer is among more than 25 drug makers who have expressed interest to supply developing countries with the vaccine under the Sh300-per-dose plan led by the World Health Organization.
However, the company must first fulfill pre-purchase orders signed with the United States, European Union and a few other rich countries running into millions of doses, to be supplied this year.
Pfizer said it will be able to supply only 50 million doses by the end of this year, and around 1.3 billion by the end of 2021.
READ MORE:
- Hope To The World As Covid-19 Drug Is Announced
- Esther Passaris Badly Trolled For Comparing Herself To Kamala Harris
- Kenya urged not to Depot Tanzanian Politician Arrested While Fleeing From Tanzania
Prizer, which developed the vaccine with the German drugmaker BioNTech, published a statement saying the vaccine is more than 90 percent effective in preventing Covid-19 in participants without evidence of prior SARS-CoV-2 infection.
Kenya is relying on the WHO-led Covx facility to access Covid-19 vaccines at Sh300 per dose.
